Interim considerations for disposition of hospitalized patients with 2019-nCoV infection

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.
• Description:
  Currently, limited information is available to characterize the spectrum of clinical illness, transmission efficiency, and the duration of viral shedding for 2019-nCoV infection. Interim guidance for disposition of hospitalized patients with 2019-nCoV infection has been developed based on available 2019-nCoV information and what is known about related coronaviruses (MERS-CoV and SARS-CoV). This guidance is subject to change as additional information becomes available.
  
  The following is intended to serve as a framework for patient disposition. All patients should be evaluated on a case-by-case basis and their disposition discussed with health care providers and public health departments.
  
  For Hospitalized Patients with Confirmed 2019-nCoV infection -- For Non-Hospitalized Patients with Confirmed 2019-nCoV infection.
  
  
• Subjects:
  Coronavirus Infections COVID-19 Hospitalization Pandemics Respiratory Tract Infections
• Series:
  Coronavirus Disease 2019 (COVID-19)
• Document Type:
  Text
• Genre:
  Guideline
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:63c18804f3f5affe75d418ad267a9e924e7d31e5de8ddcfd8c19bbe7d4723d241f21b7f0f98e5ac0a7139d1befa7f25aabe71675288311bcd0e550b422e6d174
• Download URL:
  https://stacks.cdc.gov/view/cdc/84974/cdc_84974_DS1.pdf
• File Type:
  [PDF - 59.42 KB ]